✦ LIBER ✦

Pharmaceutical development of IPI-504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer

✍ Scribed by James R. Porter; Julian Adams; Rebecca Ahn; Vince Ammoscato; Brendan Arsenault; Brian C. Austad; Gary Baker; Johan Basuki; Marlene R. Booth; Matthew J. Campbell; Bennett Carter; Michael Curtis; Kris Depew; Mark A. Douglas; Jie Ge; Louis Grenier; Joseph Helble; John Henderson; Natalie Goltz; Dumitru Ionescu; Laila Kott; Jason T. Kropp; John Lee; Kaiming Li; Bradley Maurer; Denise Mayes; Roger H. Pak; Jason Piotrowski; Jennifer R. Porter; David Rusch; Geoff E. Sylvester; Steven Wong; Jim Wright

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 162 KB
Volume: 71
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.20383

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An experimental study and clinical pilot

An experimental study and clinical pilot trials on Yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer

✍ Zhi-Ping Yan; Gui Lin; Hui-Yang Zhao; Yong-Hua Dong 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

ChemInform Abstract: An Improved Synthes

ChemInform Abstract: An Improved Synthesis of Enantiomerically Pure RWJ 69442, a Development Candidate for the Treatment of Benign Prostatic Hyperplasia.

✍ Gee-Hong Kuo; Catherine Prouty; William V. Murray; Rekha D. Shah 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 39 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v